For Healthcare Professionals: Our Range

Our range of generic and branded medicines and medical devices includes prescription medicines used in primary and secondary care and covers a broad range of therapeutic areas.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

To contact Teva's Medical Information Service email: medinfo@tevauk.com or telephone: 0207 540 7117.

To contact Customer Services about the supply and availability of a medicine email: customer.services@tevauk.com or telephone: 0800 590 502.

Available as
  • Film-coated Tablets
Available as
  • Capsules
  • Tablets
Available as
  • PR Tablets
  • Tablets
Available as
  • Film-coated Tablets
Available as
  • Capsules
Available as
  • Capsules
  • Oral solution
Available as
  • Granules
Available as
  • S/F Oral solution
Available as
  • Concentrate for Dispersion for Infusion
Available as
  • Hard Capsules
Available as
  • Film-coated Tablets
Available as
  • Film-coated Tablets
1 2 3 4 5 6 7 8 9 10

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Teva using the Reporting Side Effects Form or email uk.safety@tevauk.com.


Medicines showing this symbol are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects experienced through the Yellow Card Scheme.

Date of preparation: February 2022
Reference: COB-GB-NP-00077

Date of preparation: February 2022
Reference: COB-GB-00006